Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS ... discuss the array of existing and emerging classes of drugs that could benefit those with ACOS and share their ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Scientists at Rutgers Health have made a groundbreaking discovery that could transform how asthma is diagnosed and monitored.

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Black Americans have a higher likelihood of having asthma-COPD overlap syndrome (ACOS) but may not know it. Here’s what you ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...

TSLP has been found to play a key role in different immune diseases, such as boosting inflammation in asthma and COPD. WIN378 ...